Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Candida albicans
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
===Systemic infections=== Systemic fungal infections ([[fungemia]]s) including those by ''C. albicans'' have emerged as important causes of [[morbidity]] and [[death|mortality]] in [[immunodeficiency|immunocompromised]] patients (e.g., [[HIV/AIDS|AIDS]], cancer [[chemotherapy]], organ or [[bone marrow]] transplantation). ''C. albicans'' often forms biofilms inside the body. Such ''C. albicans'' [[biofilm]]s may form on the surface of implantable medical devices or organs. In these biofilms it is often found together with ''[[Staphylococcus aureus]]''.<ref name="Kumamoto2002"/><ref name="Donlan2001"/><ref>{{cite journal | vauthors = Peters BM, Jabra-Rizk MA, Scheper MA, Leid JG, Costerton JW, Shirtliff ME | title = Microbial interactions and differential protein expression in Staphylococcus aureus -Candida albicans dual-species biofilms | journal = FEMS Immunology and Medical Microbiology | volume = 59 | issue = 3 | pages = 493β503 | date = August 2010 | pmid = 20608978 | pmc = 2936118 | doi = 10.1111/j.1574-695X.2010.00710.x }}</ref><ref>{{cite journal | vauthors = Saygin D, Tabib T, Bittar HE, Valenzi E, Sembrat J, Chan SY, Rojas M, Lafyatis R | display-authors = 6 | title = Transcriptional profiling of lung cell populations in idiopathic pulmonary arterial hypertension | journal = Pulmonary Circulation | volume = 10 | issue = 1 | pages = 30β39 | year = 2013 | pmid = 32166015 | doi = 10.1893/0005-3155-84.1.30 | pmc = 7052475 | s2cid = 96930404 }}</ref> Such multispecies infections lead to higher mortalities.<ref>{{cite journal | vauthors = Zago CE, Silva S, SanitΓ‘ PV, Barbugli PA, Dias CM, Lordello VB, Vergani CE | title = Dynamics of biofilm formation and the interaction between Candida albicans and methicillin-susceptible (MSSA) and -resistant Staphylococcus aureus (MRSA) | journal = PLOS ONE | volume = 10 | issue = 4 | pages = e0123206 | year = 2015 | pmid = 25875834 | pmc = 4395328 | doi = 10.1371/journal.pone.0123206 | doi-access = free | bibcode = 2015PLoSO..1023206Z }}</ref> In addition [[nosocomial infection|hospital-acquired infections]] by ''C. albicans'' have become a cause of major health concerns.<ref name=Calderone/><ref>{{cite book |title=Mibrobiology:an Introduction | vauthors = Tortora GJ |publisher=Pearson Benjamin Cummings |year=2010 |location=San Francisco, CA |pages=758}}</ref> Especially once candida cells are introduced in the bloodstream a high mortality, up to 40β60% can occur.<ref name=Calderone>{{cite book |veditors=Calderone A, Clancy CJ |title=Candida and Candidiasis |edition=2nd |publisher=ASM Press |year=2012 |isbn=978-1-55581-539-4}}</ref><ref>{{cite journal | vauthors = Weinberger M, Leibovici L, Perez S, Samra Z, Ostfeld I, Levi I, Bash E, Turner D, Goldschmied-Reouven A, Regev-Yochay G, Pitlik SD, Keller N | display-authors = 6 | title = Characteristics of candidaemia with Candida-albicans compared with non-albicans Candida species and predictors of mortality | journal = The Journal of Hospital Infection | volume = 61 | issue = 2 | pages = 146β154 | date = October 2005 | pmid = 16009456 | doi = 10.1016/j.jhin.2005.02.009 }}</ref> Although ''Candida albicans'' is the most common cause of [[fungemia|candidemia]], there has been a decrease in the incidence and an increased isolation of non-albicans species of ''Candida'' in recent years.<ref>{{cite journal | vauthors = Yapar N | title = Epidemiology and risk factors for invasive candidiasis | journal = Therapeutics and Clinical Risk Management | volume = 10 | pages = 95β105 | date = 2016-04-16 | pmid = 24611015 | pmc = 3928396 | doi = 10.2147/TCRM.S40160 | doi-access = free }}</ref> Preventive measures include maintaining a good oral hygiene, keeping a healthy lifestyle including good nutrition, the careful use of antibiotics, treatment of infected areas and keeping skin dry and clean, free from open wounds.<ref>"Fungal Diseases." Centers for Disease Control and Prevention, Centers for Disease Control and Prevention, 12 June 2015, www.cdc.gov/fungal/diseases/candidiasis/invasive/diagnosis.html.</ref><ref>{{cite web|url=http://www.microbiologybook.org/mycology/mycology-3.htm|title=Yeasts|website=www.microbiologybook.org|access-date=27 March 2018|archive-date=14 March 2018|archive-url=https://web.archive.org/web/20180314095810/http://www.microbiologybook.org/mycology/mycology-3.htm|url-status=live}}</ref>
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)